Tag Directory / PUBLICHEALTH     showing 21–40 of 215



Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC / Healthcare Dive

Rebecca Pifer Parduhn / healthcaredive - It’s looking increasingly likely that the UnitedHealth and CVS drug middlemen will also make peace with federal regulators, after Cigna agreed to a sweeping settlement in the insulin lawsuit last month.

#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy #healthcarefinance


Saturday, March 7, 2026, 12:23 am / permalink 20308 / 3 stories in 9 days


Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology / MedCity

Frank Vinluan / medcitynews - Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If Moderna’s full financial payout to the companies is reache…

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #healthcarefinance #infectiousdisease


Saturday, March 7, 2026, 12:22 am / permalink 20307 / 3 stories in 9 days


FDA vaccine chief to step down in April / Beckers

Ella Jeffries / beckershospitalreview - Vinay Prasad, MD, the FDA’s top regulator of vaccines and cell and gene therapies, will step down at the end of April, an agency spokesperson confirmed to Becker’s. Dr. Prasad joined the agency in 2025 on a one-year sabbatical from the University of Calif…

#healthcare #publichealth #governmentpolicy #biotech #drugdevelopment #fda #vaccinesafety #infectiousdisease


Friday, March 6, 2026, 6:23 pm / permalink 20292 / 3 stories in 10 days


Hospitals urge regulators to halt drugmakers’ expanded 340B data policies / Healthcare Dive

Emily Olsen / healthcaredive - The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.

#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy #hospitaloperations #healthcarefinance


Friday, March 6, 2026, 12:23 pm / permalink 20277 / 4 stories in 10 days


GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people / Medical Express

medicalxpress - A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn't use a patch. He didn't set a quit date. He simply lost interest. It happen…

#obesity #healthcare #pharmaceuticals #elililly #novonordisk #weightloss #publichealth #drugdevelopment #behavioralhealth


Friday, March 6, 2026, 12:23 pm / permalink 20276 / 10 stories in 10 days


AI blood test finds silent liver disease years before symptoms / Science Daily Cancer

sciencedaily - Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go unnoticed until serious damage occurs. By analyzing genome-wid…

#healthcare #publichealth #biotech #digitalhealth #medicaldevices #healthcarefinance


Friday, March 6, 2026, 1:22 am / permalink 20251 / 7 stories in 10 days


Groundbreaking new drug shows promise for treating children with a devastating form of epilepsy / LiveScience

livescience - An experimental treatment reduces seizures and other symptoms in children with a type of epilepsy called Dravet syndrome.

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda #infanthealth


Thursday, March 5, 2026, 4:23 pm / permalink 20233 / 4 stories in 11 days


Adding Hormone Therapy to PORT Might Not Benefit Patients with Recurrent Prostate Cancer and PSA of 0.5 ng/mL or Less / ESMO

esmo - Findings from the POSEIDON meta-analysis of the MARCAP consortium

#healthcare #pharmaceuticals #publichealth #oncology


Thursday, March 5, 2026, 3:23 am / permalink 20175 / 3 stories in 11 days


RFK Jr. names 2 new members to CDC vaccine panel / Beckers

Erica Cerutti / beckershospitalreview - HHS Secretary Robert F. Kennedy Jr. appointed two new members to the CDC’s vaccine advisory committee Feb. 27, ahead of a rescheduled meeting in mid-March where members are expected to review COVID-19 vaccine recommendations. Mr. Kennedy said Sean Downing…

#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety #infectiousdisease


Monday, March 2, 2026, 3:24 pm / permalink 20024 / 9 stories in 14 days


Parents of gravely ill child refused respite care / BBC

bbc - Birmingham Children's Trust refused respite help and suggested training grandparents to help.

#healthcare #publichealth #governmentpolicy #behavioralhealth


Monday, March 2, 2026, 2:22 am / permalink 19974 / 5 stories in 14 days


After 4-Week Strike, Kaiser Permanente Workers Score Tentative Win on Staffing & Pay / MedCity

Katie Adams / medcitynews - About 31,000 Kaiser Permanente workers ended a four-week strike after reaching a tentative agreement that includes measures to address chronic understaffing and wage increases. The full contract has not yet been ratified.The post After 4-Week Strike, Kais…

#healthcare #publichealth #hospitaloperations #healthcarefinance


Saturday, February 28, 2026, 12:22 pm / permalink 19945 / 8 stories in 16 days


CMS freezes $260M in Medicaid funding to Minnesota, citing fraud concerns / Beckers

Jakob Emerson / beckershospitalreview - CMS is freezing $259.5 million in federal Medicaid funding to Minnesota, citing unsupported or potentially fraudulent claims in the state’s program. “We have decided to temporarily halt certain amounts of Medicaid funding that are going to the state of Mi…

#publichealth #cdc #wildlife #animalhealth #zoonoticdisease #avianinfluenza #infectiousdisease


Saturday, February 28, 2026, 5:22 am / permalink 19939 / 3 stories in 16 days


Microplastics discovered in prostate tumors / Medical Express

medicalxpress - Small fragments of plastic were found in 9 out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds. The small, single-center study was led by researchers at NYU Langone Health, its …

#healthcare #publichealth #oncology


Saturday, February 28, 2026, 12:23 am / permalink 19928 / 4 stories in 16 days


Boehringer wins accelerated approval for first-line use of lung cancer drug / Endpoints

Lei Lei Wu / endpoints - The FDA greenlit an expanded label for Boehringer Ingelheim’s lung cancer drug Hernexeos, marking the first use of the Commissioner's National Priority Voucher for a new indication. Boehringer won an accelerated

#healthcare #pharmaceuticals #publichealth #governmentpolicy #biotech #drugdevelopment #fda #oncology


Saturday, February 28, 2026, 12:23 am / permalink 19927 / 9 stories in 16 days


Patient dies in MacroGenics' cancer study, FDA puts trial on hold / Endpoints

Max Gelman / endpoints - The FDA has placed a partial clinical hold on MacroGenics’ Phase 2 study in gynecologic cancers after one patient died and three others experienced life-threatening side effects, the company disclosed Tuesday. The patient who died ...

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda #oncology


Saturday, February 28, 2026, 12:23 am / permalink 19925 / 3 stories in 16 days


UHS posts 11.5% operating margin in 2025 as net income jumps 30% / Beckers

Andrew Cass / beckershospitalreview - King of Prussia, Pa.-based Universal Health Services recorded a net income of $1.5 billion in 2025, up from $1.1 billion in 2024, according to its Feb. 25 financial report. Eight things to know: 1. The for-profit system reported an operating income of $2 …

#healthcare #publichealth #governmentpolicy #behavioralhealth #hospitaloperations #healthcarefinance


Friday, February 27, 2026, 11:25 am / permalink 19887 / 10 stories in 17 days


Cancer blood test fails to catch disease earlier in major study / Medical Express

medicalxpress - A blood test designed to find cancer early did not work as hoped in a major new study, according to the company that makes it.

#healthcare #publichealth #governmentpolicy #biotech #medicaldevices #oncology


Thursday, February 26, 2026, 7:24 pm / permalink 19851 / 7 stories in 18 days


More Research, Less Cancer: £250m raised to transform the future of cancer research / Cancer Research UK

Charlotte Mathé / cancerresearchuk - We’ve reached an incredible moment - £250m raised for our More Research, Less Cancer campaign. This milestone brings us more than halfway to our £400m goal and accelerates our mission to prevent, detect and treat cancer earlier and more effectively. The p…

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #oncology


Tuesday, February 24, 2026, 1:24 pm / permalink 19675 / 53 stories in 20 days


FDA Launches Framework to Accelerate Individualized Therapies for Ultra-Rare Diseases 2026 / OncoDaily

oncodaily - The U.S. Food and Drug Administration (FDA) has released groundbreaking draft guidance introducing a new regulatory framework designed to accelerate the development and approval of individualized therapies for patients with […]

#healthcare #pharmaceuticals #publichealth #governmentpolicy #biotech #drugdevelopment #fda


Tuesday, February 24, 2026, 12:25 pm / permalink 19669 / 6 stories in 20 days


ChatGPT Health performance in a structured test of triage recommendations / Nature

Ashwin Ramaswamy / nature - Nature Medicine, Published online: 23 February 2026; doi:10.1038/s41591-026-04297-7A stress test of ChatGPT Health triage revealed missed high-risk emergencies and inconsistent activation of suicide-crisis safeguards, raising safety concerns for consumer-…

#healthcare #publichealth #governmentpolicy #fda #digitalhealth #medicaldevices


Tuesday, February 24, 2026, 11:25 am / permalink 19660 / 18 stories in 20 days


Back to Top


PUBLICHEALTH Heatmap


90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.



More Top Stories...


FDA refuses to review Moderna mRNA flu vaccine application

Moderna’s mRNA flu vaccine application has been rejected by the FDA—Moderna received a refusal‐to‐file letter while accusing the agency of shifting its review standards. Multiple reports echo this regulatory setback, fueling industry concerns over consistent, transparent decision‐making. More...


FDA CRL halts AstraZeneca’s Saphnelo prefilled pen approval

AstraZeneca’s application to market its subcutaneous prefilled pen formulation of Saphnelo for treating lupus has hit a roadblock after the FDA issued a complete response letter. The decision delays the drug’s approval and raises questions about its future in the competitive immunotherapy market. More...


CMS proposes sweeping changes to ACA marketplace plan rules

CMS has proposed a major rule reshaping Affordable Care Act marketplace policies, including loosening limits on non-standard plan designs and promoting lower-premium options such as catastrophic coverage. The agency says the changes will reduce costs and boost flexibility, while critics warn they could increase confusion and weaken consumer protections—because shopping for insurance clearly wasn’t complicated enough. More...


Tenet forecasts major ACA exchange enrollment drop and financial hit

Tenet Healthcare is warning that the expiration of enhanced Affordable Care Act premium tax credits will drive a steep reduction in ACA exchange enrollment, projecting a significant revenue impact in 2026. Despite the headwind, the company says it expects earnings growth, leaning on acuity and operational performance—because nothing calms Wall Street like “we’ll make it up somewhere else.” More...


City of Hope promotes Nisha Morris to senior marketing chief

City of Hope named Nisha Morris as Senior Vice President and Chief Marketing and Communications Officer, adding marketing leadership to its executive team. The move signals a renewed focus on brand, outreach, and patient engagement as the cancer center sharpens its communication and growth strategies. More...



NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.